Prostanoid receptors: Subtypes and signaling

Annual Review of Pharmacology and Toxicology

Volumn 41, Issue , 2001, Pages 661-690

  Breyer, R M ^a   Bagdassarian, C K ^a   Myers, S A ^a   Breyer, M D ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Alternative splicing; G protein; GPCR; Mutagenesis; Prostaglandin

Indexed keywords

AMINO ACID; ARACHIDONIC ACID; COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTANOID; PROSTANOID RECEPTOR; THROMBOXANE A2;

AMINO ACID SEQUENCE; ANIMAL CELL; ARACHIDONIC ACID METABOLISM; AUTOCRINE EFFECT; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; HUMAN; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0035042253     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.41.1.661     Document Type: Review

References (157)

1. Segmental synthesis and actions of prostaglandins along the nephron
2. Prostanoid biosynthesis and mechanisms of action
3. VIII. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
4. Prostanoid receptors: Structures, properties, and functions
5. GCRDb: A G-proteincoupled receptor database
6. Structural features required for ligand binding to the beta-adrenergic receptor
7. Substitution of charged amino acid residues in transmembrane regions 6 and 7 affect ligand binding signal transduction of the prostaglandin EP3 receptor
8. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
9. Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor
10. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
11. Functional interaction of prostaglandin E receptor EP3 subtype with guanine nucleotide-binding proteins, showing low-affinity ligand binding
12. Clinical implications of prostaglandin and thromboxane A2 formation, 1
13. Increased renal formation of thromboxane A2 and prostaglandin F2 alpha in heart failure
14. Chronic thromboxane receptor blockade reduces renal injury in murine lupus nephritis
15. Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: Effects of insulin therapy in the rat
16. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder
17. Cloning and expression of cDNA for a human thromboxane A2 receptor
18. Mouse thromboxane A2 receptor: cDNA cloning, expression and northern blot analysis
19. Rat kidney thromaboxane A2 receptor: Molecular cloning signal transduction and intrarenal expression localization
20. Cloning and characterization of an endogenous COS-7 cell thromboxane A2 receptor
21. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor
22. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
23. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha
24. Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo
25. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites
26. Selective coupling of prostaglandin E receptor EP3D to Gi and Gs through interaction of alpha-carboxylic acid of agonist and arginine residue of seventh transmembrane domain
27. Functional interaction of the carboxylic acid group of agonists and the arginine residue of the seventh transmembrane domain of prostaglandin E receptor EP3 subtype
28. Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling
29. The role of N-glycosylation of human thromboxane A2 receptor in ligand binding
30. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets
31. Coupling of thromboxane A2 receptor isoforms to Galphal 3: Effects on ligand binding and signalling
32. Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein
33. Internalization of the TXA2 receptor alpha and beta isoforms. Role of the differentially spliced COOH terminus in agonist-promoted receptor internalization
34. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for prostacyclin-mediated desensitization
35. Failure of parturition in mice lacking the prostaglandin F receptor
36. Cloning and expression of a cDNA for the human prostanoid FP receptor
37. Cloning and expression of a cDNA for mouse prostaglandin F receptor
38. Molecular cloning and expression of a cDNA of the bovine Prostglandin F2a receptor
39. Cloning and expression of a cDNA for rat prostaglandin F2 alpha receptor
40. Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor
41. 1 subtype
42. In situ hybridization and localization of mRNA for the rabbit prostaglandin EP3 receptor
43. Possible role for lig- and binding of histidine 81 in the second transmembrane domain of the rat prostaglandin F2alpha receptor
44. Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton
45. Differential regulation of prostaglandin F(2alpha) receptor isoforms by protein kinase C
46. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: A comparison with the rabbit isolated ear artery
47. A novel inhibitory prostanoid receptor in piglet saphenous vein
48. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein
49. Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla
50. Prostanoids and their receptors
51. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
52. A new prostaglandin E receptor mediates calcium influx and acrosome reaction in human spermatozoa
53. Prostanoid receptor with a novel pharmacological profile in human erythroleukemia cells
54. Molecular evolution of receptors for eicosanoids
55. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney
56. Detection and quantitation of EP3 prostaglandin E2 receptor mRNA along mouse nephron segments by RT-PCR
57. 4 receptor
58. Differential localization of prostaglandin E receptor subtypes in human kidney
59. 1 subtype of prostaglandin E receptor
60. 1 subtype
61. Human prostanoid receptors: Cloning and characterization
62. Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor
63. 8-chlorodibenz[B,F] [l,4]oxazepine-10 (11H)-carboxylic acid, 2-[3-2-(furanylmethyl)thio]-1-oxopropyl]hydrazide (SC51322): A potent PGE2 antagonist and analgesic
64. N-substituted dibenzoxazepines as analgesic PGE2 antagonists
65. 1 receptor antagonist blocks the diarrheagenic, but not cytoprotective, actions of a synthetic prostaglandin
66. G-protein-coupled receptor heterodimerization modulates receptor function
67. Identification and molecular characterization of m3 muscarinic receptor dimers
68. Dimerization of the delta opioid receptor: Implication for a role in receptor internalization
69. Identification of prostaglandin E receptor EP2 cloned from mastocytoma cells as EP4 subtype
70. 2 subtype
71. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype
72. Cloning and functional expression of the rabbit prostaglandin EP2 receptor
73. The mouse prostaglandin E receptor EP2 subtype: Cloning, expression, and northern blot analysis
74. Molecular cloning and expression of the rat prostaglandin E2 receptor of the EP2 subtype
75. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2)
76. Prostaglandin E2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation
77. Hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
78. Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma
79. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
80. Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979
81. A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs
82. A conserved threonine in the second extracellular loop of the human EP2 and EP4 receptors is required for ligand binding
83. 2 receptor function
84. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist
85. Molecular cloning and expression of human EP3 receptors: Evidence for three variants with different termini
86. Splice variants of the human EP3 receptor for prostaglandin E2
87. Cloning and expression of the EP3-subtype of human receptors for prostaglandin E2
88. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
89. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype
90. Urinary concentrating function in mice lacking the EP3 receptors for prostaglandin E2
91. Two isoforms of the EP3 receptor with different carboxyl-terminal domains
92. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity
93. Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase
94. Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals
95. C-46275: A potent, long acting gastric antisecretory prostaglandin with low oral bioavailability in the dog
96. SC-46275: A potent and highly selective agonist at the EP3 receptor
97. Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors
98. Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogues
99. Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid
100. The second extracellular loop of the prostaglandin EP3 receptor is an essential determinant of ligand selectivity
101. Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: Requirement for two different tyrosine kinases
102. EP3 receptor activation of cAMP response element mediated gene transcription
103. Prostaglandin E receptor EP3 subtype induces neurite retraction via small GTPase Rho
104. p160 RhoA-binding kinase ROKalpha induces neurite retraction
105. Constitutively active Galpha12, Galpha13, and Galphaq induce Rho-dependent neurite retraction through different signaling pathways
106. Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)channels
107. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: Involvement of EP1 and EP3 receptor subtypes
108. Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity
109. Constitutive activity of human prostaglandin E receptor EP3 isoforms
110. Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope
111. Nuclear localization of prostaglandin E2 receptors
112. Different membrane targeting of prostaglandin EP3 receptor isoforms dependent on their carboxy-terminal tail structures
113. Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2
114. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype
115. Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype
116. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice
117. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
118. Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor
119. The long cytoplasmic carboxyl terminus of the prostaglandin E2 receptor EP4 subtype is essential for agonist-induced desensitization
120. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
121. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
122. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension
123. cDNA cloning of a mouse prostacyclin receptor: Multiple signaling pathways and expression in thymic medulla
124. Cloning and expression of a cDNA for the human prostanoid IP receptor
125. In situ hybridization studies on prostacyclin receptor mRNA expression in various mouse organs
126. Renal action of prostacyclin
127. Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles
128. Relationship between renin release and blood pressure response to nonsteroidal anti-inflammatory drugs in hypertension
129. Stimulation of renin release by PGE2 and PGI2 infusion in the dog: Enhancing effect of ureteral occlusion or administration of ethacrynic acid
130. Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa
131. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
132. A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors
133. Cloning and expression of a cDNA for the human prostacyclin receptor
134. Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system
135. Amino acid residues conferring ligand binding properties of prostaglandin I and prostaglandin D receptors; identification by site-directed mutagenesis
136. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE
137. Prostaglandin D2 and sleep regulation
138. Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats
139. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist
140. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor
141. Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain
142. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene
143. Molecular cloning and characterization of the human prostanoid DP receptor
144. Classification of platelet and vascular prostaglandin D2 (DP) receptors: Estimation of affinities and relative efficacies for a series of novel bicyclic ligands
145. Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl- secretion in dog tracheal epithelium
146. G protein-coupled receptors. I. Diversity of receptor-ligand interactions
147. Prediction of transmembrane segments in proteins utilising multiple sequence alignments
148. The probable arrangement of the helices in G protein-coupled receptors
149. Cloning and expression of three isforms of the human EP3 prostanoid receptor
150. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: Multiple messenger systems and tissue-specific distributions
151. Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor
152. Molecular cloning and intrarenal localization of rat prostaglandin E2 receptor EP3 subtype
153. Functional difference between two isoforms of rat kidney prostaglandin receptor EP3 subtype
154. Molecular cloning and expression of a prostaglandin E2 receptor of the EP3 beta subtype from rat hepatocytes
155. Analysis of a porcine EP3-receptor: Cloning, expression and signal transduction